These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 8823150)

  • 1. Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy.
    Epstein M; Bakris G
    Arch Intern Med; 1996 Sep; 156(17):1969-78. PubMed ID: 8823150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fixed-dose combination therapy: reduction of side effects with enhanced tolerance and antihypertensive efficacy].
    González Maqueda I; Gómez Guindal JA; González Lama I
    Rev Esp Cardiol; 1999; 52 Suppl 3():59-72. PubMed ID: 10614151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When antihypertensive monotherapy fails: fixed-dose combination therapy.
    Weir MR
    South Med J; 2000 Jun; 93(6):548-56. PubMed ID: 10881767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for the use of very-low-dose combinations as first-line treatment of hypertension.
    Waeber B; Brunner HR
    J Hypertens Suppl; 2001 Nov; 19(4):S3-8. PubMed ID: 11848261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.
    Neutel JM
    Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
    Abe M; Okada K; Matsumoto K
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
    Tocci G; Palano F; Pagannone E; Chin D; Ferrucci A; Volpe M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fixed-dose combinations in the first line of antihypertensive therapy].
    Urbán L; Mészáros A
    Acta Pharm Hung; 2007; 77(3):180-4. PubMed ID: 18019783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for single-pill triple therapy in hypertension.
    Elijovich F; Laffer C
    Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):231-40. PubMed ID: 19443512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with ACE inhibitors/angiotensin II receptor antagonists and diuretics in hypertension.
    Waeber B
    Expert Rev Cardiovasc Ther; 2003 May; 1(1):43-50. PubMed ID: 15030296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The need for combination antihypertensive therapy to reach target blood pressures: what has been learned from clinical practice and morbidity-mortality trials?
    Struijker-Boudier HA; Ambrosioni E; Holzgreve H; Laurent S; Mancia G; Ruilope LM; Waeber B
    Int J Clin Pract; 2007 Sep; 61(9):1592-602. PubMed ID: 17686100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving blood pressure control rates by optimizing combination antihypertensive therapy.
    Epstein BJ
    Expert Opin Pharmacother; 2010 Aug; 11(12):2011-26. PubMed ID: 20590485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The combination of an ACE inhibitor and a calcium channel blocker is an optimal combination for the treatment of hypertension].
    Widimský J
    Vnitr Lek; 2009 Feb; 55(2):123-30. PubMed ID: 19348394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy as first-line treatment of arterial hypertension.
    Ruzicka M; Leenen FH
    Can J Cardiol; 2002 Dec; 18(12):1317-27. PubMed ID: 12518184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safe and effective management of hypertension with fixed-dose combination therapy: focus on losartan plus hydrochlorothiazide.
    Benedict CR
    Int J Clin Pract; 2000; 54(1):48-54. PubMed ID: 10750261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.